Filters
The investigational drug zuranolone (SAGE-217) appears to improve multiple aspects of sleep when administered in the 5-hour phase advance model of transient insomnia, according to the results of a phase I study.
Individuals with high intake of vitamin K1 or K2, regardless of dietary sources, are at low risk of developing atherosclerotic cardiovascular disease (ASCVD), a study has found.
